1dy9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1dy9" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dy9, resolution 2.1&Aring;" /> '''INHIBITION OF THE HEP...)
Line 1: Line 1:
-
[[Image:1dy9.gif|left|200px]]<br /><applet load="1dy9" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1dy9.gif|left|200px]]<br /><applet load="1dy9" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1dy9, resolution 2.1&Aring;" />
caption="1dy9, resolution 2.1&Aring;" />
'''INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)'''<br />
'''INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)'''<br />
==Overview==
==Overview==
-
The hepatitis C virus NS3 protein contains a serine protease domain with a, chymotrypsin-like fold, which is a target for development of therapeutics., We report the crystal structures of this domain complexed with NS4A, cofactor and with two potent, reversible covalent inhibitors spanning the, P1-P4 residues. Both inhibitors bind in an extended backbone conformation, forming an anti-parallel beta-sheet with one enzyme beta-strand. The P1, residue contributes most to the binding energy, whereas P2-P4 side chains, are partially solvent exposed. The structures do not show notable, rearrangements of the active site upon inhibitor binding. These results, are significant for the development of antivirals.
+
The hepatitis C virus NS3 protein contains a serine protease domain with a chymotrypsin-like fold, which is a target for development of therapeutics. We report the crystal structures of this domain complexed with NS4A cofactor and with two potent, reversible covalent inhibitors spanning the P1-P4 residues. Both inhibitors bind in an extended backbone conformation, forming an anti-parallel beta-sheet with one enzyme beta-strand. The P1 residue contributes most to the binding energy, whereas P2-P4 side chains are partially solvent exposed. The structures do not show notable rearrangements of the active site upon inhibitor binding. These results are significant for the development of antivirals.
==About this Structure==
==About this Structure==
-
1DY9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Viruses Viruses] with ZN as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DY9 OCA].
+
1DY9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Viruses Viruses] with <scene name='pdbligand=ZN:'>ZN</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DY9 OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Viruses]]
[[Category: Viruses]]
[[Category: Colarusso, S.]]
[[Category: Colarusso, S.]]
-
[[Category: Francesco, R.De.]]
+
[[Category: Francesco, R De.]]
-
[[Category: Marco, S.Di.]]
+
[[Category: Marco, S Di.]]
-
[[Category: Matassa, V.G.]]
+
[[Category: Matassa, V G.]]
[[Category: Narjes, F.]]
[[Category: Narjes, F.]]
[[Category: Rizzi, M.]]
[[Category: Rizzi, M.]]
Line 29: Line 29:
[[Category: serine protease]]
[[Category: serine protease]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 13:40:24 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:21:46 2008''

Revision as of 10:21, 21 February 2008


1dy9, resolution 2.1Å

Drag the structure with the mouse to rotate

INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)

Overview

The hepatitis C virus NS3 protein contains a serine protease domain with a chymotrypsin-like fold, which is a target for development of therapeutics. We report the crystal structures of this domain complexed with NS4A cofactor and with two potent, reversible covalent inhibitors spanning the P1-P4 residues. Both inhibitors bind in an extended backbone conformation, forming an anti-parallel beta-sheet with one enzyme beta-strand. The P1 residue contributes most to the binding energy, whereas P2-P4 side chains are partially solvent exposed. The structures do not show notable rearrangements of the active site upon inhibitor binding. These results are significant for the development of antivirals.

About this Structure

1DY9 is a Single protein structure of sequence from Viruses with as ligand. Full crystallographic information is available from OCA.

Reference

Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes., Di Marco S, Rizzi M, Volpari C, Walsh MA, Narjes F, Colarusso S, De Francesco R, Matassa VG, Sollazzo M, J Biol Chem. 2000 Mar 10;275(10):7152-7. PMID:10702283

Page seeded by OCA on Thu Feb 21 12:21:46 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools